FI94837C - Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina - Google Patents

Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina Download PDF

Info

Publication number
FI94837C
FI94837C FI884192A FI884192A FI94837C FI 94837 C FI94837 C FI 94837C FI 884192 A FI884192 A FI 884192A FI 884192 A FI884192 A FI 884192A FI 94837 C FI94837 C FI 94837C
Authority
FI
Finland
Prior art keywords
water
monoester
solution
solutions
solid solution
Prior art date
Application number
FI884192A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI884192A0 (fi
FI94837B (fi
FI884192A (fi
Inventor
Lorenz Hahn
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI884192A0 publication Critical patent/FI884192A0/fi
Publication of FI884192A publication Critical patent/FI884192A/fi
Application granted granted Critical
Publication of FI94837B publication Critical patent/FI94837B/fi
Publication of FI94837C publication Critical patent/FI94837C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI884192A 1987-09-15 1988-09-13 Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina FI94837C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3730909 1987-09-15
DE3802355 1988-01-27
DE3802355 1988-01-27

Publications (4)

Publication Number Publication Date
FI884192A0 FI884192A0 (fi) 1988-09-13
FI884192A FI884192A (fi) 1989-03-16
FI94837B FI94837B (fi) 1995-07-31
FI94837C true FI94837C (fi) 1995-11-10

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884192A FI94837C (fi) 1987-09-15 1988-09-13 Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina

Country Status (24)

Country Link
JP (1) JP3090666B2 (it)
KR (1) KR0131084B1 (it)
AT (1) AT395819B (it)
AU (1) AU628787B2 (it)
BE (1) BE1001204A5 (it)
CA (1) CA1338775C (it)
CH (1) CH683672A5 (it)
DK (1) DK175132B1 (it)
ES (1) ES2012118A6 (it)
FI (1) FI94837C (it)
FR (1) FR2620336B1 (it)
GB (1) GB2209671B (it)
GR (1) GR1002243B (it)
HU (1) HU205010B (it)
IE (1) IE61195B1 (it)
IL (1) IL87746A (it)
IT (1) IT1224886B (it)
LU (1) LU87335A1 (it)
MY (1) MY103769A (it)
NL (1) NL195094C (it)
NO (1) NO179434C (it)
NZ (1) NZ226163A (it)
PT (1) PT88492B (it)
SE (1) SE503279C2 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DE69307505T2 (de) 1992-05-13 1997-07-24 Sandoz-Patent-Gmbh, 79539 Loerrach Opthalmische zusammensetzungen enthaltend ein cyclosporin
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
DE69435104D1 (de) * 1993-09-28 2008-07-31 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
BR9807528A (pt) 1997-01-30 2000-03-14 Novartis Ag Composições farmacêuticas isentas de óleo contendo ciclosporina a
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AU2003267747A1 (en) * 2003-10-14 2005-05-05 Ramesh Varada Bapat Sterile gelling agents
JP5422871B2 (ja) * 2006-10-24 2014-02-19 不二製油株式会社 イソフラボン類組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (it) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (it) * 1966-11-22 1968-06-21
BE787842A (fr) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤

Also Published As

Publication number Publication date
SE8803221L (sv) 1989-03-16
PT88492B (pt) 1993-03-31
GB8821443D0 (en) 1988-10-12
MY103769A (en) 1993-09-30
IT1224886B (it) 1990-10-24
ATA224988A (de) 1992-08-15
NO884052L (no) 1989-03-16
FR2620336B1 (fr) 1991-10-25
ES2012118A6 (es) 1990-03-01
NO179434C (no) 1996-10-09
SE503279C2 (sv) 1996-05-13
BE1001204A5 (fr) 1989-08-16
AT395819B (de) 1993-03-25
JP3090666B2 (ja) 2000-09-25
DK175132B1 (da) 2004-06-14
NO179434B (no) 1996-07-01
AU628787B2 (en) 1992-09-24
GB2209671B (en) 1991-11-13
NL195094C (nl) 2003-12-17
SE8803221D0 (sv) 1988-09-13
LU87335A1 (fr) 1989-04-06
FI884192A0 (fi) 1988-09-13
KR0131084B1 (ko) 1998-04-17
FI94837B (fi) 1995-07-31
GR880100602A (el) 1989-06-22
NL8802275A (nl) 1989-04-03
IT8848349A0 (it) 1988-09-14
DK511188D0 (da) 1988-09-14
JPH01151526A (ja) 1989-06-14
IE882772L (en) 1989-03-15
DK511188A (da) 1989-03-16
FI884192A (fi) 1989-03-16
KR890004694A (ko) 1989-05-09
NZ226163A (en) 1991-08-27
FR2620336A1 (fr) 1989-03-17
NO884052D0 (no) 1988-09-13
GB2209671A (en) 1989-05-24
AU2217288A (en) 1989-04-27
IL87746A (en) 1992-07-15
CH683672A5 (de) 1994-04-29
IE61195B1 (en) 1994-10-19
PT88492A (pt) 1988-10-01
HUT49494A (en) 1989-10-30
CA1338775C (en) 1996-12-10
HU205010B (en) 1992-03-30
IL87746A0 (en) 1989-02-28
GR1002243B (en) 1996-04-22

Similar Documents

Publication Publication Date Title
FI94837C (fi) Vesiliukoisia monoestereitä käytettäväksi farmakologisesti aktiivisten yhdisteiden kantajana ja farmaseuttisten apuaineiden liukoisuutta lisäävinä aineina
US5756450A (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
DE69635720T2 (de) Pharmazeutische Zusammensetzungen von Cyclosporine mit einer Polyethoxylierten hydroxy-fettsäure
US5543393A (en) Cyclosporin containing powder composition
JP4073503B2 (ja) サイクロスポリンを含有する液体製剤とその調製方法
EP0650721B1 (en) Cyclosporin soft capsule
FI89065C (fi) Foerfarande foer framstaellning av en ny siklosporin kristallform
KR980008239A (ko) 사이클로스포린-함유 약학적 조성물
KR100471680B1 (ko) 사이클로스포린제제
HU213394B (en) Process for producing pharmaceutical compositions containing cyclosporins as active components
JPH10508306A (ja) 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US6187747B1 (en) Pharmaceutical composition comprising cyclosporin
JP2003507343A (ja) 経口及び局所投与用の医薬組成物
EP0982035B1 (en) Cyclosporin composition comprising an hydrophilic carrier
EP1151755B1 (en) Pharmaceutical compositions comprising cyclosporin as active ingredient
KR100308779B1 (ko) 사이클로스포린을함유한신규조성물
WO2010141068A1 (en) Opthalmic compositions of cyclosporin
DE3830494B4 (de) Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe
AU3043400A (en) Cyclosporin solution
KR0173349B1 (ko) 사이클로스포린-함유 고체 분산체 조성물
SK123299A3 (en) Pharmaceutical compositions containing cyclosporin

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired